Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

12th International Workshop on Non-Hodgkin Lymphoma /
Meeting highlights from the 12th iwNHL 2014: Day 2

5th - 7th Sep 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.10.14
Views: 2905

Prof John Gribben; Dr Myron Czuczman; Dr Wyndham Wilson; Prof Anton Hagenbeek; Professor Michael Pfreundschuh

Prof Gribben (Bart's Cancer Institute, London, UK) chairs a discussion with Dr Czuczman (Roswell Park Cancer Institute, Buffalo, USA), Prof Hagenbeek (Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands), Professor Pfreundschuh (University of Saarland, Homburg-Saar, Germany) and Dr Wilson (National Cancer Institute, Bethesda, USA) about the highlights from day two of the 12th International Workshop on Non-Hodgkin Lymphoma.

They consider the lessons that can be learnt from myeloma biology and therapies and apply to NHL; novel lymphoma targets, including IMiDs, proteasome inhibitors, Bcl-2 inhibitors, CAR T cells, and the dual targeting of proteolytic degradation pathways.

In addition, they reflect upon the idea of a chemo-free treatment era.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation